Pierre‐Yves Le Prise

789 total citations
14 papers, 633 citations indexed

About

Pierre‐Yves Le Prise is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Pierre‐Yves Le Prise has authored 14 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in Pierre‐Yves Le Prise's work include Lymphoma Diagnosis and Treatment (5 papers), Acute Lymphoblastic Leukemia research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Pierre‐Yves Le Prise is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Acute Lymphoblastic Leukemia research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Pierre‐Yves Le Prise collaborates with scholars based in France, Switzerland and United States. Pierre‐Yves Le Prise's co-authors include Thierry Lamy, R Fauchet, Bernard Drénou, Brigitte Birebent, Marc Bernard, A Beauplet, Mehdi Alizadeh, Dominique Bories, Bruno Danic and Erwann Quelvennec and has published in prestigious journals such as Blood, British Journal of Haematology and Leukemia Research.

In The Last Decade

Pierre‐Yves Le Prise

14 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre‐Yves Le Prise France 11 257 194 185 171 108 14 633
B Varet France 12 376 1.5× 227 1.2× 260 1.4× 194 1.1× 159 1.5× 46 874
Sou‐Ming Chuang Taiwan 15 212 0.8× 168 0.9× 190 1.0× 145 0.8× 114 1.1× 25 681
Maya Thangavelu United States 17 494 1.9× 187 1.0× 287 1.6× 140 0.8× 318 2.9× 36 1.2k
Sylvie Ramond France 13 402 1.6× 274 1.4× 145 0.8× 67 0.4× 312 2.9× 18 792
MJ Brisco Australia 9 191 0.7× 228 1.2× 342 1.8× 172 1.0× 128 1.2× 9 706
NK Ramsay United States 9 501 1.9× 313 1.6× 87 0.5× 141 0.8× 77 0.7× 11 755
Beatrice D. Spector United States 8 102 0.4× 354 1.8× 240 1.3× 352 2.1× 141 1.3× 10 892
DR Head United States 9 519 2.0× 168 0.9× 191 1.0× 114 0.7× 236 2.2× 14 890
VM Santana United States 9 240 0.9× 310 1.6× 119 0.6× 101 0.6× 185 1.7× 11 674
AM Levine United States 15 290 1.1× 339 1.7× 297 1.6× 204 1.2× 229 2.1× 22 893

Countries citing papers authored by Pierre‐Yves Le Prise

Since Specialization
Citations

This map shows the geographic impact of Pierre‐Yves Le Prise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre‐Yves Le Prise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre‐Yves Le Prise more than expected).

Fields of papers citing papers by Pierre‐Yves Le Prise

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre‐Yves Le Prise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre‐Yves Le Prise. The network helps show where Pierre‐Yves Le Prise may publish in the future.

Co-authorship network of co-authors of Pierre‐Yves Le Prise

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre‐Yves Le Prise. A scholar is included among the top collaborators of Pierre‐Yves Le Prise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre‐Yves Le Prise. Pierre‐Yves Le Prise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Linassier, Claude, B Desablens, Thierry Lefrancq, et al.. (2002). Stage I-IIE Primary Non-Hodgkin's Lymphoma of the Testis: Results of a Prospective Trial by the GOELAMS Study Group. Clinical Lymphoma. 3(3). 167–172. 32 indexed citations
2.
Alizadeh, Mehdi, Marc Bernard, Bruno Danic, et al.. (2002). Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood. 99(12). 4618–4625. 274 indexed citations
3.
Amiot, Laurence, Myriam Onno, T. Lamy, et al.. (1998). Loss of HLA molecules in B lymphomas is associated with an aggressive clinical course. British Journal of Haematology. 100(4). 655–663. 57 indexed citations
4.
Drénou, Bernard, et al.. (1998). Multidrug Resistance in Aggressive Lymphoproliferative Disorders of T and Natural-Killer Origin. Leukemia & lymphoma. 30(3-4). 381–387. 11 indexed citations
5.
Lamy, Thierry, Bernard Drénou, Olivier Fardel, et al.. (1998). Multidrug resistance analysis in lymphoproliferative disease of large granular lymphocytes. British Journal of Haematology. 100(3). 509–515. 28 indexed citations
6.
Drénou, Bernard, Thierry Lamy, Laurence Amiot, et al.. (1997). CD3−CD56+ Non-Hodgkin's Lymphomas With an Aggressive Behavior Related to Multidrug Resistance. Blood. 89(8). 2966–2974. 127 indexed citations
7.
Corlu, Anne, Virginie Gandemer, Mickaël Rialland, et al.. (1997). Rat liver biliary epithelial cells support long‐term production of haemopoietic progenitors from human CD34+ cells. British Journal of Haematology. 98(3). 560–568. 6 indexed citations
8.
Goasguen, J, Thierry Lamy, Christophe Bergeron, et al.. (1996). Multifactorial Drug-Resistance Phenomenon in Acute Leukemias: Impact of P170-MDR1, LRP56 Protein, Glutathione-Transferases and Metallothionein Systems on Clinical Outcome. Leukemia & lymphoma. 23(5-6). 567–576. 18 indexed citations
9.
10.
Lamy, Thierry, et al.. (1992). Lung Abscess due to <i>Pseudallescheria boydii</i> in the Course of Acute Leukaemia. Acta Haematologica. 87(1-2). 78–82. 15 indexed citations
11.
Ghandour, C, et al.. (1985). Hodgkin’s Disease and Hyperthyroidism. Acta Haematologica. 74(3). 137–143. 4 indexed citations
12.
David, Jean‐Claude, et al.. (1985). DNA ligases in human leukemia. Leukemia Research. 9(7). 851–858. 8 indexed citations
13.
Pennec, Yvon, Dominique Mottier, Pierre Youinou, et al.. (1983). Critical Study of Staging in Multiple Myeloma. Scandinavian Journal of Haematology. 30(2). 183–190. 22 indexed citations
14.
Lessard, Michel & Pierre‐Yves Le Prise. (1982). Cytogenetic studies in 56 cases with Ph1-positive hematologic disorders. Cancer Genetics and Cytogenetics. 5(1). 37–49. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B Varet Breakdown of academic impact, for papers by Sou‐Ming Chuang Breakdown of academic impact, for papers by Maya Thangavelu Breakdown of academic impact, for papers by Sylvie Ramond Breakdown of academic impact, for papers by MJ Brisco Breakdown of academic impact, for papers by NK Ramsay Breakdown of academic impact, for papers by Beatrice D. Spector Breakdown of academic impact, for papers by DR Head Breakdown of academic impact, for papers by VM Santana Breakdown of academic impact, for papers by AM Levine
Rankless by CCL
2026